New Zealand vs Nicaragua: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
New Zealand
0.0%
in 2024
Nicaragua
0.0%
in 2024
New Zealand rank
167th
Nicaragua rank
167th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- New Zealand
- Nicaragua
How they compare
New Zealand currently reports 0.0% against 0.0% in Nicaragua, a difference of 0.0%.
Across all 10 years both countries report, Nicaragua has been ahead every year.
New Zealand ranks 167th and Nicaragua ranks 167th of 246 countries.
Head to head by decade
| Decade | New Zealand | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, New Zealand or Nicaragua?
- New Zealand, at 0.0% against 0.0% in Nicaragua as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between New Zealand and Nicaragua?
- 0.0%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Nicaragua?
- 10 years are reported by both, from 2015 to 2024.
- How do New Zealand and Nicaragua rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- New Zealand ranks 167th and Nicaragua ranks 167th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.